Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,380,763
+$54,641 QoQ
Shares Held
3,813
+1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,485
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST FOUNDATION ADVISORS holds $34,560,047 across 8 Drug Manufacturers - General names. AMGN ranks #8 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,126 | $11,968,589 | |
| 2 | LLY |
ELI LILLY & Co
|
5,869 | $7,039,455 | |
| 3 | AZN |
Astrazeneca PLC
|
18,550 | $3,517,450 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
24,720 | $3,123,124 | |
| 5 | PFE |
Pfizer Inc
|
121,118 | $2,916,521 | |
| 6 | ABBV |
AbbVie Inc.
|
10,123 | $2,547,351 | |
| 7 | MRK |
Merck & Co., Inc.
|
16,084 | $2,066,794 | |
| 8 | AMGN |
Amgen Inc
This page
|
3,813 | $1,380,763 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,380,763 | 3,813 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,326,122 | 3,769 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $981,274 | 2,998 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $776,613 | 2,752 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $996,779 | 3,570 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $817,506 | 2,624 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $865,324 | 3,320 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,067,803 | 3,314 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,082,013 | 3,463 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $990,001 | 3,482 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,006,340 | 3,494 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,302,141 | 4,845 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $948,246 | 4,271 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,247,671 | 5,161 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,262,247 | 4,806 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $919,632 | 4,080 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $990,474 | 4,071 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,102,457 | 4,559 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,154,096 | 5,130 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $995,627 | 4,682 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,243,856 | 5,103 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,564,766 | 6,289 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $9,967,032 | 43,350 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $10,753,509 | 42,310 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,714,230 | 7,268 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,432,895 | 7,068 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||